Code : 9345-353487      Created Date : Saturday, October 14, 2017   Visit : 1494

27th European Congress of Clinical Microbiology and Infectious Diseases by Dr. Sadegh Khodavaisy

27th European Congress of Clinical Microbiology and Infectious Diseases by Dr. Sadegh Khodavaisy
sadegh khodaveisy | International Congress Form

Application Code :
762-0217-0045
 
Created Date : Thursday, August 31, 2017-13:44 13:44:04Update Date : Monday, October 2, 2017-12:27 12:27:40
IP Address : 194.225.57.35Submit Date : Monday, October 2, 2017-12:28 12:28:04Email : sadegh_7392008@yahoo.com
Personal Information
Name : Sadegh
Surname : Khodavaisy
School/Research center : School of Public Health
If you choose other, please name your Research center :  
Position : Assistant professor
Tel : +21-88-008588
Information of Congress
Title of the Congress : 27th European Congress of Clinical Microbiology and Infectious Diseases
Title of your Abstract : In vitro antifungal susceptibility profiles of nine antifungal drugs against global collection of genotyped Hortaea werneckii isolates
Destination Country : Austria
From : Saturday, April 22, 2017
To : Tuesday, April 25, 2017
Abstract(Please copy/paste the abstract send to the congress) : Background: The hyphomycete genus Hortaea represents anamorph members of the ascomycetes in the order Capnodiales comprising the black yeast-like. The aim of this study is to determine the in vitro activity of nine existing and new antifungal drugs against H. Werneckii isolates stored in the CBS collection.
Material/methods: The strains were analyzed by amplified fragment length polymorphism (AFLP) genotyping and subjected to sequencing of the elongation factor 1-alpha genes. In vitro susceptibility was determined as described in CLSI document M38-A2 for amphotericin B, itraconazole, voriconazole, Isavuconazole, posaconazole, fluconazole, caspofungin, and anidulafungin.
Results: The widest ranges and the highest MICs/MECs were seen for fluconazole and caspofungin (range 8->64 µg/ml and 1-8 µg/ml, respectively). The GM MICs/MECs against all the species of H. Werneckii tested were as follow in increasing order; posaconazole (0.07 μg/ml), voriconazole (0.13 μg/ml), isavuconazole (0.14 μg/ml), itraconazole (0.16 μg/ml), terbinafine (0.19 μg/ml), amphotericin B (0.89 μg/ml), anidulafungin (1.45 μg/ml), caspofungin (2.47 μg/ml), and fluconazole (14.38 μg/ml). There were no significant differences in the activities of the surveyed drugs against of environmental and clinical isolates (p > 0.05). The difference in the MIC90 between the strains did not differ by more than one dilution.
Conclusions: posaconazole, voriconazole and itraconazole were the most active drugs with high in vitro activity against H. werneckii. From the echinocandins tested caspofungin and anidulafungin demonstrated poor in vitro activity, those drugs might not be useful for treating a range of this fungal infections, either alone or as part of a combination therapy regimen. However, their clinical effectiveness in the treatment of infection remains to be determined.
Keywords of your Abstract : Hortaea Werneckii , antifungal susceptibility
Acceptance Letter : http://gsia.tums.ac.ir/images/UserFiles/23925/Forms/762/Acceptance_Letter_Sadegh_Kh_.pdf
The presentation : Poster
The Cover of Abstract book :
Published abstract in the abstract book with the related code : http://gsia.tums.ac.ir/images/UserFiles/23925/Forms/762/Published_Abstract.pdf
Where has your abstract been indexed? : none
If you choose other, please name :  
The Congress Reporting Form
How many volunteers were present at the Congress? : 10000
Delegates from which countries presented in the congress? : Netherlands, USA, Uk, China, Italy, Germany, Austria, Iran, Turkey, France
Were the delegates of any other organizations present in the congress? : Yes
If yes, please write the names of the organizations in the box : Other Universities
What were the responses to your talking points? Were specific questions or concerns raised? : Several questions about the diagnostic and treatment options of Invasive fungal infections were asked.
Some question was about prevalence environmental and clinical route of azole resistance in our country. I answered them generally and explained.Also,the responses to my talking points were so interesting and unbelievable.
If you met staff members, please list their full names & positions. : I talked to many of experts in medical mycology from all of other countries and Iran.
Prof. Jacques Meis, The Netherlands
Dr. Ferry Hagen, The Netherlands
Dr. Hamid Badali, Iran
 
Please inform us if there are any follow up actions we need to talk with the members of the congress : There is no specific action that could be follow up.
Your experiences about the travel processes(Providing ticket, accommodation,...) : Everything went well, but It was so expensive. Unfortunately, we have lots of problem for paying registration fee and booking hotel.I think it is responsibility of TUMS to facilitates these kind of problems.
Please give a briefing of your own observations and outcomes of the congress: : The 27th ECCMID was so interesting and organization of the congress was the great.The latest achievements in diagnosis mycos were discussed thoroughly during the specific congress. I talked to several professor from Netherlands about collaboration. I hope that there would be more chance of attending such international congresses to be able to share their valuable experience with experts around the world.

 

Your Comments :
captcha
Close